From Awareness to Action in HPV Prevention
International HPV Awareness Day highlights a critical reality: cervical cancer is largely preventable, yet screening participation remains inconsistent across populations.
Human papillomavirus (HPV) is a leading cause of cervical cancer, and early detection through screening is essential to reducing disease burden. However, despite well-established screening programmes, many individuals remain unscreened or under-screened, often due to practical, cultural, or psychological barriers.
Closing this gap requires not only awareness – but accessible, patient-centred screening solutions.
Addressing the Screening Gap
Multiple factors contribute to low screening uptake, including:
- Discomfort or anxiety associated with clinician-collected sampling
- Limited access to healthcare settings
- Cultural sensitivities and privacy concerns
- Time constraints and logistical challenges
These barriers disproportionately affect certain populations, creating inequalities in access to preventative care.
To achieve meaningful improvements in participation, screening approaches must evolve to become more flexible, acceptable, and scalable.
Self-Collection: A Transformational Approach
Self-collection for HPV testing has emerged as a scientifically validated strategy to expand access to screening. By enabling individuals to collect their own sample, self-sampling reduces reliance on clinical appointments and increases autonomy.
HPV self-sampling allows individuals to:
- Collect samples in a private, comfortable environment
- Avoid invasive procedures such as speculum examinations
- Engage with screening at a time and place that suits them
Evidence shows that self-sampling can increase participation in screening programmes, particularly among populations who would otherwise not engage with traditional pathways.
Supporting Screening Programmes with SELF FLOQSwabs®
Modern self-collection devices are central to the success of HPV self-sampling strategies. Copan’s Self Vaginal Collection FLOQSwabs® have been specifically designed to support HPV and STI screening initiatives, combining patient usability with laboratory performance. These devices enable safe, comfortable, and easy self-collection of vaginal samples, whether in a clinical setting or at home.
Designed for Patient Acceptability
- Soft, small swab tip for minimally invasive, near-painless sampling
- Ergonomic shaft and clear instructions to ensure ease of use
- Designed for privacy and autonomy, improving user confidence
The emphasis on usability is critical – improved patient experience directly correlates with increased screening uptake.
Optimised for Diagnostic Performance
Self Vaginal Collection FLOQSwabs® leverage proprietary FLOQ® technology, based on perpendicular nylon fibres that enhance specimen collection and release.
This design enables:
- Efficient sample uptake and release, improving analyte recovery
- No internal core, preventing sample entrapment
- Improved compatibility with molecular assays, including HPV DNA testing
Studies demonstrate that flocked swabs can release over 90% of collected specimen into the transport medium, supporting reliable downstream analysis.
Integration into Laboratory Workflows
For laboratories and screening programmes, self-collection devices must align with existing diagnostic infrastructure.
Self Vaginal Collection FLOQSwabs® are:
- Sterile and process-ready
- Available in configurations compatible with standard workflows
- Designed for seamless integration with molecular platforms
They support high-throughput HPV testing, enabling scalable screening strategies without compromising diagnostic quality
Driving Participation Through Innovation
Self-collection is not only a technical advancement — it is a public health strategy.
By reducing barriers to access, self-sampling approaches supported by technologies such as Self Vaginal Collection FLOQSwabs® can:
- Increase participation among never screened and under-screened populations
- Enable outreach and community-based screening programmes
- Reduce pressure on clinical services
- Improve early detection rates
Studies and programme implementations have shown that offering self-collection options can significantly increase screening uptake
Scaling Towards Cervical Cancer Elimination
Global initiatives, including those led by the WHO, aim to eliminate cervical cancer as a public health issue. Achieving this requires:
- High vaccination coverage
- High-quality HPV testing
- High participation in screening programmes
Self-collection technologies provide a critical mechanism to achieve the third objective — ensuring broader and more equitable access to screening.
International HPV Awareness Day: A Call to Action
On this International HPV Awareness Day, healthcare providers, laboratories, and programme leaders are encouraged to:
- Promote awareness of HPV and the importance of regular screening
- Implement patient-centred screening pathways, including self-collection
- Address barriers that prevent participation
- Adopt technologies that enable scalable, accessible diagnostics
By combining scientific evidence with innovative collection solutions, it is possible to expand screening coverage and improve outcomes at population level.
Conclusion
Cervical cancer prevention depends not only on scientific advances, but on ensuring those advances reach the people who need them most.
Self Vaginal Collection FLOQSwabs® represent a practical, validated approach to supporting HPV self-sampling — enabling individuals to take control of their health, while supporting laboratories and screening programmes with reliable, high-quality specimens.
Increasing participation in screening is one of the most effective ways to reduce cervical cancer — and self-collection is a key part of that future.
To learn more about Self Vaginal Collection FLOQSwabs® and how self-collection can support your HPV or STI screening programme, contact our team or explore our product range.
Get In Touch